NDC codes

415464 NDC codes with hospital pricing data in the network.

• NDC 45802-0222-11 — FLUTICASONE PROPIONATE 0.05 % TOPICAL CREAMAI (98 hospitals, 30,306–31,305 samples)
• NDC 45802-0222-35 — FLUTICASONE PROPIONATE 0.05 % TOPICAL CREAMAI (123 hospitals, 30,306–31,305 samples)
• NDC 45802-0937-16 — Hydrocortisone 2.5% lotion, 59 mL bottleAI (283 hospitals, 30,306–31,305 samples)
• NDC 45802-0880-96 — Nystatin and triamcinolone topical creamAI (63 hospitals, 30,306–31,305 samples)
• NDC 45802-0221-11 — FLUTICASONE PROPIONATE 0.005 % TOPICAL OINTMENTAI (50 hospitals, 30,306–31,305 samples)
• NDC 65162-0989-04 — Estradiol 0.025 mg/24 hr transdermal patchAI (70 hospitals, 30,306–31,305 samples)
• NDC 00713-0225-15 — TRIAMCINOLONE ACETONIDE 0.1 % TOPICAL CREAMAI (55 hospitals, 30,306–31,305 samples)
• NDC 57896-0140-01 — DICLOFENAC 1 % TOPICAL GELAI (196 hospitals, 30,306–31,305 samples)
• NDC 00121-0873-08 — Lactulose oral solution, 10 g per 15 mLAI (81 hospitals, 30,306–31,305 samples)
• NDC 00713-0632-15 — FLUTICASONE PROPIONATE 0.005 % TOPICAL OINTMENTAI (50 hospitals, 30,306–31,305 samples)
• NDC 67457-0162-02 — Sodium tetradecyl sulfate 1% injection, 2 mL vialAI (507 hospitals, 30,077–31,301 samples)
• NDC 68682-0110-01 — PIMECROLIMUS 1 % TOPICAL CREAMAI (149 hospitals, 30,319–31,300 samples)
• NDC 45802-0063-35 — Triamcinolone acetonide 0.025% cream, 15 g tubeAI (369 hospitals, 30,317–31,298 samples)
• NDC 61314-0143-10 — Brimonidine tartrate 0.2% eye dropsAI (349 hospitals, 30,305–31,295 samples)
• NDC 70069-0091-01 — Azelastine eye drops 0.05%AI (136 hospitals, 30,305–31,295 samples)
• NDC 33342-0328-15 — TRIAMCINOLONE ACETONIDE 0.5 % TOPICAL CREAMAI (104 hospitals, 30,305–31,295 samples)
• NDC 62332-0655-30 — Formoterol fumarate 20 mcg nebulizer solutionAI (82 hospitals, 30,305–31,295 samples)
• NDC 62332-0655-60 — Formoterol fumarate 20 mcg/2 mL nebulizer solutionAI (71 hospitals, 30,305–31,295 samples)
• NDC 70748-0261-30 — Formoterol fumarate 20 mcg nebulizer solutionAI (108 hospitals, 30,305–31,295 samples)
• NDC 65162-0918-38 — Lidocaine 5% ointment tubeAI (353 hospitals, 30,304–31,285 samples)
• NDC 00168-0265-15 — Betamethasone 0.05% topical creamAI (53 hospitals, 30,304–31,285 samples)
• NDC 00527-5125-78 — Lactulose oral solution, 10 grams per 15 mLAI (90 hospitals, 30,304–31,285 samples)
• NDC 45802-0055-05 — Triamcinolone 0.1% topical ointmentAI (401 hospitals, 30,303–31,284 samples)
• NDC 16714-0161-01 — CLINDAMYCIN 1 % TOPICAL GELAI (92 hospitals, 30,303–31,275 samples)
• NDC 69097-0318-87 — Budesonide 0.25 mg/2 mL nebulizer suspensionAI (119 hospitals, 30,303–31,275 samples)
• NDC 67877-0473-79 — Lidocaine 5% external ointmentAI (223 hospitals, 30,303–31,275 samples)
• NDC 69097-0318-32 — Budesonide 0.25 mg/2 mL nebulizer suspensionAI (106 hospitals, 30,303–31,275 samples)
• NDC 23155-0160-42 — ETOMIDATE 2 MG/ML INTRAVENOUS SOLUTIONAI (94 hospitals, 30,303–31,275 samples)
• NDC 70095-0050-01 — Sodium bicarbonate 8.4% intravenous solutionAI (192 hospitals, 30,341–31,268 samples)
• NDC 35573-0444-25 — Levalbuterol 0.63 mg nebulizer solutionAI (158 hospitals, 30,302–31,265 samples)
• NDC 76204-0800-25 — Levalbuterol 0.63 mg/3 mL nebulizer solutionAI (85 hospitals, 30,302–31,265 samples)
• NDC 76204-0900-15 — Levalbuterol 1.25 mg/3 mL nebulizer solutionAI (94 hospitals, 30,302–31,265 samples)
• NDC 00093-4146-45 — Levalbuterol 0.63 mg nebulizer solutionAI (156 hospitals, 30,302–31,265 samples)
• NDC 69097-0318-86 — Budesonide 0.25 mg/2 mL nebulizer suspensionAI (100 hospitals, 30,302–31,265 samples)
• NDC 70436-0151-19 — Arformoterol 15 mcg/2 mL nebulizer solutionAI (68 hospitals, 30,302–31,265 samples)
• NDC 00713-0229-15 — Triamcinolone acetonide 0.025% topical ointmentAI (98 hospitals, 30,302–31,265 samples)
• NDC 69097-0318-53 — Budesonide 0.25 mg/2 mL nebulizer suspensionAI (111 hospitals, 30,302–31,265 samples)
• NDC 00093-4146-56 — Levalbuterol 0.63 mg nebulizer solutionAI (190 hospitals, 30,302–31,265 samples)
• NDC 16714-0115-01 — Rivastigmine 4.6 mg/24 hour skin patchAI (113 hospitals, 30,301–31,255 samples)
• NDC 42291-0076-30 — CLOBETASOL 0.05 % TOPICAL CREAMAI (129 hospitals, 30,301–31,255 samples)
• NDC 42291-0077-30 — CLOBETASOL 0.05 % TOPICAL OINTMENTAI (84 hospitals, 30,301–31,255 samples)
• NDC 45802-0900-94 — CLINDAMYCIN 1 % TOPICAL GELAI (108 hospitals, 30,301–31,255 samples)
• NDC 47335-0632-48 — Budesonide 0.5 mg/2 mL nebulizer solutionAI (94 hospitals, 30,301–31,255 samples)
• NDC 51672-1259-02 — Clobetasol 0.05% ointment, 30 g tubeAI (280 hospitals, 30,301–31,255 samples)
• NDC 51672-1282-01 — Triamcinolone acetonide 0.1% topical creamAI (206 hospitals, 30,301–31,255 samples)
• NDC 60687-0244-40 — Fluoxetine oral liquid, 20 mg per 5 mLAI (105 hospitals, 30,301–31,255 samples)
• NDC 63629-2457-01 — CLOBETASOL 0.05 % TOPICAL OINTMENTAI (53 hospitals, 30,301–31,255 samples)
• NDC 69238-1532-03 — CLOBETASOL 0.05 % TOPICAL CREAMAI (133 hospitals, 30,301–31,255 samples)
• NDC 17478-0171-30 — Levalbuterol inhalation solution for nebulizerAI (141 hospitals, 30,301–31,255 samples)
• NDC 61570-0131-20 — Silvadene 1% topical creamAI (346 hospitals, 30,301–31,255 samples)